Annual Operating Expenses
$86.46 M
-$6.37 M-6.86%
31 December 2023
Summary:
Black Diamond Therapeutics annual total operating expenses is currently $86.46 million, with the most recent change of -$6.37 million (-6.86%) on 31 December 2023. During the last 3 years, it has risen by +$16.89 million (+24.28%). BDTX annual operating expenses is now -31.85% below its all-time high of $126.87 million, reached on 31 December 2021.BDTX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$18.13 M
-$4.00 M-18.08%
30 September 2024
Summary:
Black Diamond Therapeutics quarterly total operating expenses is currently $18.13 million, with the most recent change of -$4.00 million (-18.08%) on 30 September 2024. Over the past year, it has dropped by -$5.88 million (-24.50%). BDTX quarterly operating expenses is now -48.73% below its all-time high of $35.36 million, reached on 30 September 2021.BDTX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BDTX Operating Expenses Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -6.9% | -24.5% |
3 y3 years | +24.3% | -48.7% |
5 y5 years | +871.0% | +122.5% |
BDTX Operating Expenses High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -31.9% | +24.3% | -48.7% | at low |
5 y | 5 years | -31.9% | +871.0% | -48.7% | +122.5% |
alltime | all time | -31.9% | +1999.0% | -48.7% | +495.2% |
Black Diamond Therapeutics Operating Expenses History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $18.13 M(-18.1%) |
June 2024 | - | $22.13 M(+9.3%) |
Mar 2024 | - | $20.25 M(-2.9%) |
Dec 2023 | $86.46 M(-6.9%) | $20.86 M(-13.1%) |
Sept 2023 | - | $24.01 M(+19.9%) |
June 2023 | - | $20.03 M(-7.1%) |
Mar 2023 | - | $21.56 M(-1.3%) |
Dec 2022 | $92.83 M(-26.8%) | $21.85 M(-1.2%) |
Sept 2022 | - | $22.12 M(-4.5%) |
June 2022 | - | $23.17 M(-9.8%) |
Mar 2022 | - | $25.68 M(-1.5%) |
Dec 2021 | $126.87 M | $26.08 M(-26.3%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2021 | - | $35.36 M(+1.9%) |
June 2021 | - | $34.72 M(+13.0%) |
Mar 2021 | - | $30.71 M(+32.5%) |
Dec 2020 | $69.57 M(+137.2%) | $23.18 M(+25.4%) |
Sept 2020 | - | $18.48 M(+23.0%) |
June 2020 | - | $15.03 M(+16.7%) |
Mar 2020 | - | $12.88 M(+24.5%) |
Dec 2019 | $29.33 M(+229.4%) | $10.34 M(+27.0%) |
Sept 2019 | - | $8.15 M(+16.4%) |
June 2019 | - | $7.00 M(+82.2%) |
Mar 2019 | - | $3.84 M(+26.1%) |
Dec 2018 | $8.90 M(+116.2%) | $3.05 M |
Dec 2017 | $4.12 M | - |
FAQ
- What is Black Diamond Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics annual operating expenses year-on-year change?
- What is Black Diamond Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics quarterly operating expenses year-on-year change?
What is Black Diamond Therapeutics annual total operating expenses?
The current annual operating expenses of BDTX is $86.46 M
What is the all time high annual operating expenses for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high annual total operating expenses is $126.87 M
What is Black Diamond Therapeutics annual operating expenses year-on-year change?
Over the past year, BDTX annual total operating expenses has changed by -$6.37 M (-6.86%)
What is Black Diamond Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of BDTX is $18.13 M
What is the all time high quarterly operating expenses for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high quarterly total operating expenses is $35.36 M
What is Black Diamond Therapeutics quarterly operating expenses year-on-year change?
Over the past year, BDTX quarterly total operating expenses has changed by -$5.88 M (-24.50%)